Only a few of the recommendations made in this supplement are implemented in ongoing HIV remission studies that involve an analytical treatment interruption. The absence of these recommendations in protocols puts sexual partners of study participants at serious risk. This paper addresses one possible barrier to implementation: a certain misunderstanding among sponsors and research entities.
Keywords: HIV; HIV cure-related studies; analytic treatment interruption; clinical trials; human subject research; research ethics.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.